Alexandra Croockewit

Overall and event-free survival are not improved by the use of myeloablative therapy following intensified chemotherapy in previously untreated patients with multiple myeloma: a prospective randomized phase 3 study

Christine M. Segeren, Pieter Sonneveld, Bronno van der Holt et al. · Blood · 2003 · 163 citations · Full text

Medicine, Hematology, Oncology +14

Targeting CD4+ T-Helper Cells Improves the Induction of Antitumor Responses in Dendritic Cell–Based Vaccination

Erik H.J.G. Aarntzen, I. Jolanda M. de Vries, W. Joost Lesterhuis et al. · Cancer Research · 2012 · 153 citations

Medicine, Immunology, Oncology +17

Blood-derived dendritic cell vaccinations induce immune responses that correlate with clinical outcome in patients with chemo-naive castration-resistant prostate cancer

Harm Westdorp, Jeroen H. A. Creemers, Inge M. van Oort et al. · Journal for ImmunoTherapy of Cancer · 2019 · 113 citations · Full text

Medicine, Immunology, Oncology +17

Vincristine, doxorubicin and dexamethasone (VAD) administered as rapid intravenous infusion for first‐line treatment in untreated multiple myeloma

Christine M. Segeren, Pieter Sonneveld, Bronno van der Holt et al. · British Journal of Haematology · 1999 · 98 citations · Full text

Medicine, Hematology, Oncology +16

Vaccination with mRNA-Electroporated Dendritic Cells Induces Robust Tumor Antigen-Specific CD4+ and CD8+ T Cells Responses in Stage III and IV Melanoma Patients

Erik H.J.G. Aarntzen, Gerty Schreibelt, Kalijn F. Bol et al. · Clinical Cancer Research · 2012 · 98 citations

Medicine, Immunology, Oncology +17